|Articles|January 21, 2016
Celltrion Adopts Medidata Clinical Cloud
Medidata's ClinicalCloud will provide scalable technology to Celltrion's biosimilars development programs.
Advertisement
Seoul, Korea-based biopharmaceutical company Celltrion announced it has adopted Medidata's ClinicalCloud to provide scalable technology to its biosimilars development programs. The technologies include electronic data capture and management (Medidata Rave ®), medical coding (Medidata Coder ®) and randomization and trial supply management (Medidata Balance ®).
Read the full release .
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
Q&A: Strategies for Successful Global Clinical Trial DeliverySeptember 12th 2025
Vabysmo Shows Long-Term Efficacy and Safety in Wet AMD, PCV PatientsSeptember 12th 2025
Latest NIMBLE Study Results Highlight Progress in gMG ResearchSeptember 12th 2025
ACT Brief Episode 8: Expert Insights on the Future of Obesity Drug TrialsSeptember 11th 2025
Advertisement
Advertisement
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
